Actively Recruiting
Clonidine and Lorazepam Premedication for Claustrophobic Patients During MRI Scan
Led by Salem Anaesthesia Pain Clinic · Updated on 2025-01-27
50
Participants Needed
1
Research Sites
286 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Claustrophobia is an intense fear of being confined or suffocated and affects about 5% of people. This fear can make MRI scans difficult because the procedure requires lying still in a narrow tube, which can trigger claustrophobic reactions. Researchers are studying how different premedication options may help reduce claustrophobia symptoms in adults undergoing MRI scans as part of chronic pain management. The study observes adults diagnosed with claustrophobia who have previously been unable to complete an MRI due to their fear. Each participant receives different premedication treatments in rotation before alternate MRI sessions: Lorazepam 1mg, Clonidine 0.2mg, or a combination of both. These medications are given to see if they can reduce claustrophobia during the MRI. Participants will complete the Claustrophobia Questionnaire (CLQ) and the General Anxiety Disorder Questionnaire (GAD-7) on the days before and after each MRI scan to report their symptoms. Researchers will track how many patients complete the MRI scans and analyze changes in anxiety and claustrophobia scores. The study uses statistical methods to evaluate the effects of the premedications on anxiety and scan completion rates.
CONDITIONS
Official Title
Premedication for Claustrophobic Patients for MRI Scan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with claustrophobia
- Previous incomplete MRI due to claustrophobia
- Adult patients
- Good treatment compliance
- Reliable Claustrophobia Questionnaire (CLQ) diary
- Reliable General Anxiety Disorder Questionnaire (GAD) diary
- Provided informed consent for diary review
- Provided consent for clinical record quality assurance review
You will not qualify if you...
- Poor treatment compliance
- Cognitive disorder
- Unable to provide consent
- Major neuropsychiatric disorder
- Unreliable diary
- Cannabis use
- Excessive alcohol intake
- Previous adverse or allergic reactions to clonidine
- Previous adverse or allergic reactions to lorazepam
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Salem Anaesthesia Pain Clinic
Surrey, British Columbia, Canada, V3S 7J1
Actively Recruiting
Research Team
O
Olu Bamgbade, MD,FRCPC
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here